Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase

Sci Rep. 2016 Oct 24:6:35829. doi: 10.1038/srep35829.

Abstract

The endocannabinoid 2-arachidonoylglycerol (2-AG) mediates retrograde synaptic depression including depolarization-induced suppression of excitation (DSE) and inhibition (DSI). 2-AG is degraded primarily by monoacylglycerol lipase (MAGL), which is expressed in neurons and astrocytes. Using knockout mice in which MAGL is deleted globally or selectively in neurons or astrocytes, we investigated the relative contribution of neuronal and astrocytic MAGL to the termination of DSE and DSI in Purkinje cells (PCs) in cerebellar slices. We report that neuronal MAGL plays a predominant role in terminating DSE at climbing fiber (CF) to PC synapses, while both neuronal and astrocytic MAGL significantly contributes to the termination of DSE at parallel fiber (PF) to PC synapses and DSI at putative Stellate cell to PC synapses. Thus, DSE and DSI at different synapses is not uniformly affected by global and cell type-specific knockout of MAGL. Additionally, MAGL global knockout, but not cell type-specific knockout, caused tonic activation and partial desensitization of the CB1 receptor at PF-PC synapses. This tonic CB1 activation is mediated by 2-AG since it was blocked by the diacylglycerol lipase inhibitor DO34. Together, these results suggest that both neuronal and astrocytic MAGL contribute to 2-AG clearance and prevent CB1 receptor over-stimulation in the cerebellum.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Arachidonic Acids / metabolism
  • Astrocytes / physiology
  • Benzodioxoles / pharmacology
  • Benzoxazines / pharmacology
  • Cerebellum / cytology
  • Cerebellum / metabolism*
  • Endocannabinoids / metabolism*
  • Enzyme Inhibitors / pharmacology
  • Female
  • Glycerides / metabolism
  • Male
  • Mice, Knockout
  • Monoacylglycerol Lipases / antagonists & inhibitors
  • Monoacylglycerol Lipases / genetics
  • Monoacylglycerol Lipases / metabolism*
  • Morpholines / pharmacology
  • Naphthalenes / pharmacology
  • Neurons / physiology
  • Patch-Clamp Techniques
  • Piperidines / pharmacology
  • Purkinje Cells / physiology
  • Receptor, Cannabinoid, CB1 / agonists
  • Receptor, Cannabinoid, CB1 / metabolism
  • Synapses / drug effects
  • Synapses / physiology*

Substances

  • Arachidonic Acids
  • Benzodioxoles
  • Benzoxazines
  • Endocannabinoids
  • Enzyme Inhibitors
  • Glycerides
  • JZL 184
  • Morpholines
  • Naphthalenes
  • Piperidines
  • Receptor, Cannabinoid, CB1
  • (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone
  • glyceryl 2-arachidonate
  • Monoacylglycerol Lipases